The previous grant MH44212 supported the ascertainment and phenotyping of seventeen multiplex pedigrees and it provided monies for genotyping and linkage analyses. In addition to meeting the primary goals of the original grant, we carried out simulation runs to evaluate the power of the pedigree sample for linkage analysis, genotyped nine pedigrees with over 329 DNA markers and performed linkage analyses. To date, strong evidence of linkage has not been found with these DNA markers, including probes which define the D1, D2, D3, D4, and D5 dopamine receptor genes. The primary goal of the proposed grant renewal is to test the hypothesis that a major genetic locus underlies schizophrenia in a subgroup of families. The will be carried out by: 1. Enlarging our sample of 17 current pedigrees to 25 moderately sized, high density families to increase power to detect linkage. 2. A two-pronged genotyping approach. The schizophrenic pedigrees will be genotyped using a. Polymorphic candidate genes implicated in the pathophysiology of schizophrenia. b. A linkage map with simple sequence repeat (SSR) markers spaced at 5 centimorgan intervals. 3.The lod score method as well as the affected pedigree member method of linkage analysis. 4. Analysis of two neurophysiological variables, the P50 evoked auditory response and SPEM, in addition to analysis using the schizophrenia phenotype. 5. Linkage analysis with brain cDNA's that contain highly informative polymorphic microsatellite sequences. 6. Mutation scanning techniques in candidate genes that map to promising areas of linkage. 7. Use of the approaches described above to search for linkage in large pedigrees on the Micronesian island, Palau.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH044212-08
Application #
5214688
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost
Miller, Christine L; Murakami, Peter; Ruczinski, Ingo et al. (2009) Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. Schizophr Res 113:259-67
Stephens, Sarah H; Logel, Judith; Barton, Amanda et al. (2009) Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res 109:102-12
Tregellas, Jason R; Davalos, Deana B; Rojas, Donald C et al. (2007) Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res 92:262-72
Stevens, K E; O'Neill, H C; Rose, G M et al. (2006) The 5-HT(1A) receptor active compounds (R)-8-OH-DPAT and (S)-UH-301 modulate auditory evoked EEG responses in rats. Amino Acids 31:365-75
Buhler, A V; Dunwiddie, T V (2001) Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors. Neuroscience 106:55-67
Adler, L E; Olincy, A; Cawthra, E et al. (2001) Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology 24:671-9
Ross, R G; Olincy, A; Zerbe, G et al. (2001) Which duration of postsaccadic slowing identifies anticipatory saccades during smooth pursuit eye movements? Psychophysiology 38:325-33
Ross, R G; Harris, J G; Olincy, A et al. (2000) Eye movement task measures inhibition and spatial working memory in adults with schizophrenia, ADHD, and a normal comparison group. Psychiatry Res 95:35-42
Weiland, S; Bertrand, D; Leonard, S (2000) Neuronal nicotinic acetylcholine receptors: from the gene to the disease. Behav Brain Res 113:43-56
Ross, R G; Olincy, A; Harris, J G et al. (2000) Smooth pursuit eye movements in schizophrenia and attentional dysfunction: adults with schizophrenia, ADHD, and a normal comparison group. Biol Psychiatry 48:197-203

Showing the most recent 10 out of 112 publications